Antimicrobial Exposure of Expectant Mothers - - Chromatography Online
Antimicrobial Exposure of Expectant Mothers


The Column
Volume 10, Issue 13, pp. 6

Liquid chromatography–mass spectrometry (LC–MS) analysis has been performed on urine and cord blood samples from expectant mothers to explore the exposure to the antimicrobial agents triclosan (TCS) and tricarban (TCC). The agents have received increasing attention over recent years, with concerns being raised over lack of efficacy and potential toxicity to the environment, as well as human health.

TCC and TCS have been added to a range of products, from toothpaste to medical plastics, and so are now widely found throughout the population of the USA. According to the study published in the journal Environmental Science and Technology, the US FDA is to evaluate set guidelines later this year in response to concerns raised by the scientific community over their advertised antimicrobial properties.1

Urine samples were collected from 181 expectant women in Brooklyn in the USA between their 6th and 9th month of pregnancy over a period from October 2007 to December 2009. LC–MS was performed to analyze the samples. Excreted TCC was detected in more than 80% of the urine samples at low levels, TCS was found in all urine samples. TCC was detected in 8 cord-blood samples and TCS in 16 cord-blood samples. — B.D.

Reference
1. B. Pycke, L.A. Geer, M. Dalloul, O. Abulafia, A. Jenck, and R.U. Halden, Environmental Science & Technology DOI: 10.1021/es501100w (2014).

This story originally appeared in The Column. Click here to view that issue.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 

LCGC COLUMNISTS 2014

Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration


Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies


MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis


LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase


More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: The Column,
Click here